N-(4-(6-(ethylsulfonyl)pyridazin-3-yl)phenyl)cyclopentanecarboxamide结构式
|
常用名 | N-(4-(6-(ethylsulfonyl)pyridazin-3-yl)phenyl)cyclopentanecarboxamide | 英文名 | N-(4-(6-(ethylsulfonyl)pyridazin-3-yl)phenyl)cyclopentanecarboxamide |
|---|---|---|---|---|
| CAS号 | 1005307-89-0 | 分子量 | 359.4 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C18H21N3O3S | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | N-(4-(6-(ethylsulfonyl)pyridazin-3-yl)phenyl)cyclopentanecarboxamide |
|---|
| 分子式 | C18H21N3O3S |
|---|---|
| 分子量 | 359.4 |
| InChIKey | CGKPTCRVUUUENQ-UHFFFAOYSA-N |
| SMILES | CCS(=O)(=O)c1ccc(-c2ccc(NC(=O)C3CCCC3)cc2)nn1 |
|
实验名称:Discovery of Small Molecules to Inhibit Human Cytomegalovirus Nuclear Egress
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
靶标:HCMV UL50
External Id:HMS1262
|
|
实验名称:High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS1303
|